Text Messaging for Adherence in Adolescent Liver Transplant Recipients

Liver Transplant Clinical Trial

Official title:

Impact of Text Messaging on Adherence in Adolescent Liver Transplant Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01696331
• Other study ID #: 25318
• Status: Completed
• Phase: N/A
• First received: September 27, 2012
• Last updated: April 17, 2018
• Start date: September 2012
• Est. completion date: January 2013

Study information

• Verified date: April 2018
• Source: Stanford University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Text message reminders will improve adherence to lab tests in adolescent liver transplant recipients.

Description:

Adolescent patients who received a liver transplant will be recruited to participate in receiving text message reminders for lab tests. They will be send de-identified messages according to their required lab schedule. The investigators will monitor their adherence to lab tests as well as medication and clinic visits. They will also have a questionnaire about their medical regimen before and at the end of the study.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 42
• Est. completion date: January 2013
• Est. primary completion date: January 2013
• Accepts healthy volunteers: No
• Gender: All
• Age group: 12 Years to 25 Years

Eligibility

Inclusion Criteria:

• Patient >12 years

• Received liver transplant

• Followed by Stanford Liver Transplant Team

Exclusion Criteria:

• No personal cell phone

Related Conditions & MeSH terms

• Adherence
• Liver Transplant

Intervention

Behavioral:
• Text Message Reminder
Sent TM reminder at beginning and end of each month that corresponded to required lab frequency. Patients were able to send autoresponses.

Locations

Country	Name	City	State
United States	Lucile Packard Children's Hospital	Palo Alto	California

Sponsors (1)

Lead Sponsor	Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Adherence to lab tests		One year
Secondary	Texting responses	Correspondence between actual completion of tests versus reported	1 year